Prediction of venous thromboembolism in cancer patients
Top Cited Papers
- 9 December 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 116 (24), 5377-5382
- https://doi.org/10.1182/blood-2010-02-270116
Abstract
The risk of venous thromboembolism (VTE) is increased in cancer patients. To improve prediction of VTE in cancer patients, we performed a prospective and observational cohort study of patients with newly diagnosed cancer or progression of disease after remission. A previously developed risk scoring model for prediction of VTE that included clinical (tumor entity and body mass index) and laboratory (hemoglobin level and thrombocyte and leukocyte count) parameters was expanded by incorporating 2 biomarkers, soluble P-selectin, and D-Dimer. Of 819 patients 61 (7.4%) experienced VTE during a median follow-up of 656 days. The cumulative VTE probability in the original risk model after 6 months was 17.7% in patients with the highest risk score (≥ 3, n = 93), 9.6% in those with score 2 (n = 221), 3.8% in those with score 1 (n = 229), and 1.5% in those with score 0 (n = 276). In the expanded risk model, the cumulative VTE probability after 6 months in patients with the highest score (≥ 5, n = 30) was 35.0% and 10.3% in those with an intermediate score (score 3, n = 130) as opposed to only 1.0% in patients with score 0 (n = 200); the hazard ratio of patients with the highest compared with those with the lowest score was 25.9 (8.0-84.6). Clinical and standard laboratory parameters with addition of biomarkers enable prediction of VTE and allow identification of cancer patients at high or low risk of VTE.Keywords
This publication has 38 references indexed in Scilit:
- Assessing Risk of Venous Thromboembolism in the Patient With CancerJournal of Clinical Oncology, 2009
- D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis StudyJournal of Clinical Oncology, 2009
- D-dimer before chemotherapy might predict venous thromboembolismBlood Coagulation & Fibrinolysis, 2009
- Biomarkers and Venous ThromboembolismArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancerJournal of Thrombosis and Haemostasis, 2008
- High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)Blood, 2008
- Development and validation of a predictive model for chemotherapy-associated thrombosisBlood, 2008
- Predicting recurrences or major bleeding in cancer patients with venous thromboembolismThrombosis and Haemostasis, 2008
- High Concentrations of Soluble P-Selectin Are Associated with Risk of Venous Thromboembolism and the P-Selectin Thr715 VariantClinical Chemistry, 2007
- Increased soluble P‐selectin levels following deep venous thrombosis: cause or effect?British Journal of Haematology, 2000